By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Company name Capital One Financial Corp.
Stock ticker COF
Live stock price [stckqut]COF[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Poor
EPS growth Good
P/E growth Good
EBIT growth Poor

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $94.79
Target stock price (averages with growth) $129.07
Target stock price (averages with no growth) $106.1
Target stock price (manual assumptions) $94.16

 

The following company description is from Reuters: https://www.reuters.com/finance/stocks/company-profile/cof

Capital One Financial Corporation, incorporated on July 21, 1994, is a diversified financial services holding company. The Company, along with its subsidiaries, offers a range of financial products and services to consumers, small businesses and commercial clients through branches, the Internet and other distribution channels. The Company’s segments include Credit Card, Consumer Banking, Commercial Banking and Other. The Credit Card segment consists of its domestic consumer and small business card lending, and the international card lending businesses in Canada and the United Kingdom. The Consumer Banking segment consists of its branch-based lending and deposit gathering activities for consumers and small businesses, national deposit gathering, national auto lending and consumer home loan lending and servicing activities. The Commercial Banking consists of its lending, deposit gathering and treasury management services to commercial real estate, and commercial and industrial customers. The Other segment includes management of its corporate investment portfolio and asset/liability management.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in Capital One Financial Corp. as long as the price is correct and the indicators that I describe in my book The Confident Investor are favorable. Most of the fundamentals of this company are good but there are some concerns. I think there are better investment options, so I am going to remove Capital One from my Watch List.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Capital One Financial Corp. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $94.94
  • Growth: 0.1
  • Current EPS (TTM): $8.56
  • P/E: 11
  • Future EPS Calc: $13.78
  • Future Stock Price Calc: $151.64
  • Target stock price: $94.16

[/s2If]
I hope that this makes you a Confident Investor.

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Company name CEVA, Inc.
Stock ticker CEVA
Live stock price [stckqut]CEVA[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $49.31
Target stock price (averages with growth) $71.54
Target stock price (averages with no growth) $48.59
Target stock price (manual assumptions) $24.07

 

The following company description is from Reuters: https://www.reuters.com/finance/stocks/company-profile/ceva

CEVA, Inc. (CEVA), incorporated on December 3, 2003, is a licensor of signal processing intellectual property (IP). The Company partners with semiconductor companies and original equipment manufacturers (OEMs) to create connected devices for a range of end markets, including mobile, consumer, automotive, industrial and Internet of things (IoT). The Company operates through the licensing of intellectual property to semiconductor companies and electronic equipment manufacturers segment. CEVA addresses the requirements of the mobile, consumer, automotive, industrial and IoT markets by designing and licensing a range of application-specific signal processing platforms, which enable the design of solutions for developing a range of applications, including communications and connectivity, audio and voice, imaging and vision, and storage.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in CEVA, Inc. as long as the price is correct and the indicators that I describe in my book The Confident Investor are favorable. Most of the fundamentals of this company are good but there are some concerns. I think there are better companies to invest in so I am removing CEVA from my Watch List.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of CEVA, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $32
  • Growth: 0.15
  • Current EPS (TTM): $0.47
  • P/E: 41
  • Future EPS Calc: $0.94
  • Future Stock Price Calc: $38.75
  • Target stock price: $24.06

[/s2If]
I hope that this makes you a Confident Investor.

By:
On:
In: Content for book owners, Daily Indicators
With: 0 Comments
Stock ticker Stock name Last Close Recommendation
AAPL Apple Inc. $188.1500 Strong Buy or Hold
ABMD ABIOMED, Inc. $375.6700 Strong Buy or Hold, but there are some concerns
ADBE Adobe Systems Incorporated $238.3700 Strong Buy or Hold
ADS Alliance Data Systems Corporation $209.4500 Possible Buy or Hold, but some concerns
ALGN Align Technology, Inc. $286.4200 Strong Buy or Hold
ALXN Alexion Pharmaceuticals, Inc. $122.8500 Strong Buy or Hold
AMAT Applied Materials, Inc. $55.2600 Strong Buy or Hold
AMZN Amazon.com, Inc. $1601.5400 Concerned, but watch close as good things may happen soon
ANET Arista Networks Inc $253.5200 Very Concerned, may need to wait
BABA Alibaba Group Holding Ltd $198.6400 Strong Buy or Hold
BKNG Booking Holdings $2072.0200 Very Concerned, may need to wait
CBPO China Biologic Products Holdings, Inc. $83.3700 Very Concerned, may need to wait
CEVA CEVA, Inc. $31.6000 Very Concerned, may need to wait
COF Capital One Financial Corp. $93.1900 Possible Buy or Hold, but some concerns
CRTO Criteo SA (ADR) $25.9900 Very Concerned, may need to wait
CRUS Cirrus Logic, Inc. $39.3300 Strong Buy or Hold
CVCO Cavco Industries, Inc. $175.4000 Concerned, but watch close as good things may happen soon
DPZ Domino’s Pizza, Inc. $246.1400 Very Concerned, may need to wait
EW Edwards Lifesciences Corp $138.0600 Strong Buy or Hold
EXR Extra Space Storage, Inc. $94.3400 Strong Buy or Hold
FB Facebook Inc $186.6400 Strong Buy or Hold, but there are some concerns
GILD Gilead Sciences, Inc. $67.0500 Some Concerns, may need to wait
GOOGL Alphabet Inc $1106.6000 Strong Buy or Hold
GTN Gray Television, Inc. $11.7500 Possible Buy or Hold, but some concerns
GWR Genesee & Wyoming Inc $77.0600 Strong Buy or Hold
HDSN Hudson Technologies, Inc. $2.6100 Very Concerned, may need to wait
HSKA Heska Corp $94.4300 Strong Buy or Hold, but there are some concerns
HZO MarineMax Inc $23.7500 Strong Buy or Hold
IBP Installed Building Products Inc $60.3500 Strong Buy or Hold
ILMN Illumina, Inc. $269.4400 Strong Buy or Hold, but there are some concerns
LGIH LGI Homes Inc $61.8300 Very Concerned, may need to wait
LRCX Lam Research Corporation $204.0300 Strong Buy or Hold
LULU Lululemon Athletica inc. $98.7200 Concerned, but watch close as good things may happen soon
MCK McKesson Corporation $151.0200 Strong Buy or Hold
MEI Methode Electronics Inc. $41.7500 Strong Buy or Hold
MIDD Middleby Corp $105.9600 Very Concerned, may need to wait
MKTX MarketAxess Holdings Inc. $199.6300 Very Concerned, may need to wait
MRK Merck & Co., Inc. $59.6800 Strong Buy or Hold
MU Micron Technology, Inc. $53.0000 Strong Buy or Hold
NFLX Netflix, Inc. $328.5300 Strong Buy or Hold
NVDA NVIDIA Corporation $255.3600 Strong Buy or Hold
REGN Regeneron Pharmaceuticals Inc $309.5400 Possible Buy or Hold, but some concerns
SBUX Starbucks Corporation $57.1300 Very Concerned, may need to wait
SCHW Charles Schwab Corp $58.9300 Strong Buy or Hold
STZ Constellation Brands, Inc. $221.8200 Very Concerned, may need to wait
SUI Sun Communities Inc $93.2400 Very Concerned, may need to wait
SWKS Skyworks Solutions Inc $99.0200 Strong Buy or Hold
TGS Transportadora de Gas del Sur SA (ADR) $17.0500 Very Concerned, may need to wait
THRM Gentherm Inc $34.8500 Strong Buy or Hold
TMO Thermo Fisher Scientific Inc. $217.4100 Strong Buy or Hold
TMUS T-Mobile US Inc $56.4600 Very Concerned, may need to wait
TNET TriNet Group Inc $52.6300 Very Concerned, may need to wait
UNH United HealthGroup Inc $242.9000 Strong Buy or Hold
ULTA Ulta Beauty Inc $247.0400 Very Concerned, may need to wait

By:
On:
In: Daily gains
With: 0 Comments
Symbol Stock Price change today
ALXN Alexion Pharmaceuticals, Inc. 2.6659%
CEVA CEVA, Inc. 2.5974%
MU Micron Technology, Inc. 2.2771%
BABA Alibaba Group Holding Ltd 2.2021%
SWKS Skyworks Solutions Inc 2.072%
UNH United HealthGroup Inc 1.9389%
IBP Installed Building Products Inc 1.7707%
HSKA Heska Corp 1.6579%
GILD Gilead Sciences, Inc. 1.3452%
LRCX Lam Research Corporation 1.2305%
MCK McKesson Corporation 1.2131%
HZO MarineMax Inc 1.0638%
CRUS Cirrus Logic, Inc. 1.0534%
ILMN Illumina, Inc. 0.9176%
REGN Regeneron Pharmaceuticals Inc 0.8471%
ABMD ABIOMED, Inc. 0.8023%
AMAT Applied Materials, Inc. 0.7659%
STZ Constellation Brands, Inc. 0.722%
ADS Alliance Data Systems Corporation 0.6729%
NFLX Netflix, Inc. 0.6341%
COF Capital One Financial Corp. 0.6046%
TMO Thermo Fisher Scientific Inc. 0.3971%
NVDA NVIDIA Corporation 0.3261%
GOOGL Alphabet Inc 0.2918%
LULU Lululemon Athletica inc. 0.1827%
TMUS T-Mobile US Inc 0.1241%
BKNG Booking Holdings 0.0014%
GTN Gray Television, Inc. 0%
THRM Gentherm Inc 0%
MRK Merck & Co., Inc. -0.0168%
ALGN Align Technology, Inc. -0.0244%
EW Edwards Lifesciences Corp -0.0362%
AMZN Amazon.com, Inc. -0.0855%
FB Facebook Inc -0.1872%
AAPL Apple Inc. -0.2333%
SBUX Starbucks Corporation -0.2445%
GWR Genesee & Wyoming Inc -0.2847%
LGIH LGI Homes Inc -0.5629%
HDSN Hudson Technologies, Inc. -0.5714%
SCHW Charles Schwab Corp -0.8914%
SUI Sun Communities Inc -0.9245%
EXR Extra Space Storage, Inc. -0.9554%
CVCO Cavco Industries, Inc. -1.1274%
TGS Transportadora de Gas del Sur SA (ADR) -1.1594%
TNET TriNet Group Inc -1.1643%
ULTA Ulta Beauty Inc -1.184%
MIDD Middleby Corp -1.2672%
CBPO China Biologic Products Holdings, Inc. -1.3606%
ADBE Adobe Systems Incorporated -1.4511%
DPZ Domino’s Pizza, Inc. -1.5085%
MEI Methode Electronics Inc. -1.533%
ANET Arista Networks Inc -2.4585%
CRTO Criteo SA (ADR) -2.6227%
MKTX MarketAxess Holdings Inc. -2.9651%

By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments

Company name China Biologic Products Holdings, Inc.
Stock ticker CBPO
Live stock price [stckqut]CBPO[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Fair

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $130.58
Target stock price (averages with growth) $135.88
Target stock price (averages with no growth) $92.3
Target stock price (manual assumptions) $121.87

 

The following company description is from Reuters: https://www.reuters.com/finance/stocks/company-profile/cbpo

China Biologic Products Holdings, Inc. is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing, and sales of human plasma-based biopharmaceutical products in China. It operates through the manufacture and sales of human plasma products segment. China Biologic has a product portfolio with over 20 various dosage forms of plasma products and other biopharmaceutical products across nine categories.

The Company’s products include human albumin, human immunoglobulin, immunoglobulin for intravenous injection (IVIG), human hepatitis B immunoglobulin, human rabies immunoglobulin, human tetanus immunoglobulin, placenta polypeptide, Factor VIII and human prothrombin complex concentrate (PCC). The Company offers human albumin for the treatment of shock caused by blood loss trauma or burn, raised intracranial pressure caused by hydrocephalus or trauma, edema or ascites caused by hepatocirrhosis and nephropathy, prevention and treatment of low-density-lipoproteinemia, and neonatal hyperbilirubinemia. It offers human immunoglobulin and IVIG for the treatment of original immunoglobulin deficiency, such as X chain low immunoglobulin, familiar variable immune deficiency, immunoglobulin G secondary deficiency, secondary immunoglobulin deficiency, such as infection and newborn sepsis, and auto-immune deficiency diseases, such as original thrombocytopenia purpura or kawasaki disease. It offers human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis. It offers human rabies immunoglobulin for passive immunity from bites or claws by rabies or other infected animals. It offers human tetanus immunoglobulin for the prevention and therapy of tetanus. It offers placenta polypeptide for the treatment for cell immunity deficiency diseases, viral infection and leucopenia caused by various reasons, and also in postoperative healing. It offers Factor VIII for the treatment for coagulopathies, such as hemophilia A and increased concentration of coagulation factor VIII. It offers PCC for the treatment of congenital and acquired clotting factor II, VII, IX, X deficiency, such as Hemophilia B, excessive anticoagulant, and vitamin K deficiency.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in China Biologic Products Holdings, Inc. as long as the indicators that I describe in my book The Confident Investor are favorable.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of China Biologic Products Holdings, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $84.52
  • Growth: 0.15
  • Current EPS (TTM): $2.38
  • P/E: 41
  • Future EPS Calc: $4.78
  • Future Stock Price Calc: $196.26
  • Target stock price: $121.86

[/s2If]
I hope that this makes you a Confident Investor.